Journal
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 24, Issue 7, Pages 324-331Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2013.03.005
Keywords
T1DM; islet; GWAS; insulin
Categories
Funding
- Margaret Q. Landenberger Foundation
- National Institutes of Health [K08-DK089117, 5-P01-DK-049210-15]
- Charles H. Humpton, Jr. Endowment
Ask authors/readers for more resources
Type 1 diabetes mellitus (T1DM) is a chronic disease resulting from destruction of insulin-producing pancreatic beta cells. Genetic and environmental factors contribute to T1DM onset. Use of high-throughput DNA sequencing has allowed geneticists to perform genome-wide association studies (GWAS) to identify novel gene loci associated with T1DM. Interestingly, >50% of these genes encode products that are expressed in beta cells. These studies, coupled with emerging molecular evidence that beta cells are impaired by gain-of-function or loss-of-function of these loci, suggest an active role for the beta cell in eliciting its own demise. Although immune dysregulation plays a vital role in T1DM pathogenesis, understanding the mechanisms contributing to beta cell failure may lead to new strategies to preserve or improve beta cell function in patients with T1DM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available